Nutraceuticals, Diagnostics
Radiopharmaceuticals and Immunotherapeutics
from our
SINGLE DOMAIN ANTIBODY
DISCOVERY PLATFORM
based on
SYNTHETIC sdAb LIBRARIES
(VHHs or nanobodies)
Cortalix
Cortalix is a biotechnological company capable of developing Neutraceuticals, Diagnostics, ImmunoPET, targeted ImmunoRT and Immunotherapeutics for novel targets, based on its proprietary single domain antibody (sdAb, VHH or nanobody) discovery platform, which includes multiple synthetic sdAb libraries.
Cortalix operates on the basis of a business model consisting of three pillars:
1: Internal programs
Cortalix has a growing number of Internal Programs of selected sdAb clinical candidates targeting PDGFRA, PDGFRB, FAP, IGF2R, and EGFR for ImmunoPET, ImmunoRT and Immunotherapy in fibrosis and fibrotic cancers. These programs are available for licensing.
2: Partner programs
Cortalix works with companies and academic research groups in partner programs to screen and select suitable sdAb candidates for novel targets using the synthetic sdAb discovery platform. We can develop these sdAbs in close collaboration into fully-fledged applications. We can connect our selected, characterized and functionalized sdAbs seamlessly to parties in the downstream process, such as a research cell bank in Pichia pastoris to CDMOs involved in GMP production.
3: Services
We also offer stand-alone sdAb selection and development projects on a fee-for-service basis for CROs, biotech and pharma companies and research groups for very different applications, including neutraceuticlas, targeted therapy, immunotherapy, but also for research tools and bioanalytical applications such as immunohistochemistry, fluorescence imaging, tailored affinity columns, and ELISA development and validation.
Latest open positions
Internship Life Sciences for 1st half 2025, starting January 2025
Job description: Internship Life Sciences for 1st half of 2025, starting January 2025.Type: 80% – 100%, dependent on requirements master or bachelor program.Location: Innolab Agrifood, Groningen, The Netherlands.Date: Immediate.About the role At Cortalix we can...
No new internships available for 2024.
Due to the large number of applications for internships at Cortalix, we no longer have internships available for 2024. We will therefore no longer process new applications. Our sincere apologies for that.
Latest news and events
Cortalix will present at Festival of Biologics in Basel, Switzerland, 15-17 October 2024
Herman Steen, CEO of Cortalix, will present a poster "A Synthetic Single-domain Antibody Discovery Platform for the Selection of Radiopharmaceuticals for Novel Fibrosis Targets" at the Festival of Biologics, October 15-17, 2024 in Basel, Switzerland. You are cordially...
Cortalix will present at PepTalk San Diego, CA, January 13-16 2025
Herman Steen, CEO of Cortalix, will present on "Single-Domain Antibody-Based Radiopharmaceuticals for Novel Cancer Stroma Targets" at the 24th Annual PepTalk Summit US, January 13-16, 2025 in San Diego, CA. For more information about Cortalix: www.cortalix.com Contact...
CONTACT US
If you would like to know more about our organization, or would like to know how we can support your projects, please complete the contact form. We will contact you shortly.